Print Magazine
Brussels Morning Newspaper
Tuesday, September 26, 2023
No Result
View All Result
  • Home
    • About Us
  • EU institutions
    • Commission
    • Parliament
    • Council
  • Europe
  • World
  • Economy
  • Culture and Society
  • In Depth
    • Ambassador’s Corner
    • The American Angle
    • Sustainable Perspective
    • Europe With Transparency
    • Place de la Bourse
    • The Macro-Economist
    • Southeast Europe
Brussels Morning Newspaper
  • Home
    • About Us
  • EU institutions
    • Commission
    • Parliament
    • Council
  • Europe
  • World
  • Economy
  • Culture and Society
  • In Depth
    • Ambassador’s Corner
    • The American Angle
    • Sustainable Perspective
    • Europe With Transparency
    • Place de la Bourse
    • The Macro-Economist
    • Southeast Europe
Brussels Morning Newspaper
No Result
View All Result
Home EU Institutions

EU regulators probing Chinese prenatal genetic test

Ivan Fischer by Ivan Fischer
7 September 2021
in EU Institutions
European,Flags,In,Front,Of,The,European,Commission,Headquarters,Building
Share on FacebookShare on Twitter

Brussels (Brussels Morning) Healthcare regulators are probing a popular, Chinese-made prenatal genetic test following discovery that the company producing the tests has ties with the People’s Liberation Army (PLA) of China.

Regulators in three EU countries – Germany, Slovenia and Estonia – as well as in Australia and Canada, are concerned about the use of private information of pregnant women undergoing the tests, with Slovenia and Germany investigating possible breaches of EU data protection rules.

The widespread Nifty test is sold in at least 52 countries and has already been taken by 8.4 million women in the world. The genetic test, produced by the Shenzhen-based BGI Group, collects DNA samples of pregnant women and their foetuses, which are then sent to the company’s Shenzhen lab.

The women are required to sign consent forms, giving permission for their blood and DNA samples to be shipped abroad and used for research. The test itself screens for Down Syndrome markers and around 80 other potential genetic abnormalities.

The concern lies in the possibility that BGI was using the samples to research traits of populations, with several studies showing the test was developed and improved in collaboration with the PLA. The company is also reportedly cooperating with the PLA in other areas of research.

The privacy policy on BGI’s website clearly states that data collected through Nifty testing can be shared for national security purposes in China. While the company says it has never done so, the Chinese national security laws would forbid the company to admit it has complied with security agencies’ requests, even if it had.

Slovenian company GenePlanet, which sells Nifty tests across Europe, claims it is operating in accordance with EU regulations, and that the genetic data of its clients was used for research in China only with informed consent. The company also insists that none of the patient data is going to mainland China.

Tags: Main-Slider
Follow Brussels Morning
Facebook Twitter Youtube Linkedin

About Us

Brussels Morning is a daily online newspaper based in Belgium. BM publishes unique and independent coverage on international and European affairs. With a Europe-wide perspective, BM covers policies and politics of the EU, significant Member State developments, and looks at the international agenda with a European perspective.

More Info

  • About Us
  • Advertising
  • Cookie Policy
  • Contact Us
  • FAQ
  • Jobs

Categories

  • Belgium News
  • Brussels
  • Culture and Society
  • Economy
  • EU Institutions
  • Commission
  • Council
  • Parliament
  • Europe
  • Features
  • Health & Fitness
  • In Depth
  • Ambassador’s Corner
  • Europe With Transparency
  • Place de la Bourse
  • Southeast Europe
  • Sustainable Perspective
  • The American Angle
  • The Macro-Economist
  • Member States
  • Opinion
  • Our pick
  • Uncategorised
  • World
  • Diplomacy
  • Middle East Eye
  • US Elections
  • Join Our Newsletter

    Brussels Morning Newspaper – All Rights Reserved © 2020

    No Result
    View All Result
    • Home
    • About Us
    • Brussels Bubble
      • Parliament
      • Commission
      • Council
    • Wider Europe
      • Member States
    • World
    • Business & Society
    • Europe With Transparency
    • Culture & Society
    • Policy Talks
      • Place de la Bourse
      • The Macro-Economist
      • Sustainable Perspective
      • Ambassador’s Corner
      • The American Angle
      • Southeast Europe
    • Print Magazine

    Brussels Morning Newspaper - All Rights Reserved © 2020

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
    Cookie settingsACCEPT
    Privacy & Cookies Policy

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
    Non-necessary
    Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
    SAVE & ACCEPT